Search results
Results from the WOW.Com Content Network
It is given by injection into a vein. [2] Side effects may include irritation of the vein in which it is given, high blood sugar, and swelling. [2] [3] Excess use may result in low blood sodium and other electrolyte problems. [2] Intravenous sugar solutions are in the crystalloid family of medications. [4]
D10W, D 10 W dextrose 10% in water (intravenous sugar solution) da da: give DAW dispense as written (i.e., no generic substitution) DC, dc, D/C, disc discontinue [or] discharge ambiguous meaning decoct. decoctum: decoction det. detur: let it be given dieb. alt. diebus alternis: every other day; on alternate days dil. dilute dim. dimidius: one-half
Parenteral nutrition is indicated in cancer patients when it is not possible to access the digestive tract or if the tract is ineffective. In advanced cancer patients, the use of PN should be discussed in context of the risks and benefits, such as if the approximate survival rate is longer than 3 months and if PN would be expected to greatly ...
Cancer cell membranes have about sixteen times more insulin and IGF receptors than normal cells, and these receptors react with synthetic insulin. When insulin is administered, the cancer starves for glucose and generates enzyme activity that makes the cell membrane more permeable. The chemotherapy drug gets absorbed by the cancer.
Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein.The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not—due to reduced mental states or otherwise—consume food or water by mouth.
A sterile version is used for making solutions that will be given by injection. [2] Before such use other substances generally must be added to make the solution isotonic. [3] Isotonic solutions containing water for injection can be given by injection into a vein, muscle, or under the skin. [4]
Adolescent and young adult oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer in adolescent and young adult (AYA) patients aged 16–40. Studies have continuously shown that while pediatric cancer survival rates have gone up, the survival rate for adolescents and young adults has remained stagnant.
Childhood cancer is cancer in a child. About 80% of childhood cancer cases in high-income countries are being able to treat with modern treatments and good medical care. [2] [3] Yet, only 10% of children with cancer live in high-income countries where proper treatment and care are available.